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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYA spontaneously reverted iPSC line was identified from an A-T subject with heterozygous ATM truncation mutations. The reverted iPSC
line expressed ATM protein and was capable of radiation-induced phosphorylation of CHK2 and H2A.X. Genome-wide SNP analysis
confirmed a match to source T cells and also to a distinct, non-reverted iPSC line from the same subject. Rearranged T cell receptor
sequences predict that the iPSC culture originated as several independently reprogrammed cells that resolved into a single major clone,
suggesting that gene correction likely occurred early in the reprogramming process. Gene expression analysis comparing ATM/ iPSC
lines to unrelated ATM+/ cells identifies a large number of differences, but comparing only the isogenic pair of A-T iPSC lines reveals
that the primary pathway affected by loss of ATM is a diminished expression of p53-related mRNAs. Gene reversion in culture, although
likely a rare event, provided a novel, reverted cell line for studying ATM function.INTRODUCTION
Ataxia-telangiectasia (A-T) is caused by the loss of function
of the ATM gene, usually as a heterozygotic combination of
two allelicmutations. Inmost cases,ATMmutations lead to
expression of truncated proteins through early termina-
tion, but there are a large number of variations inmutation
sites (Concannon and Gatti, 1997; Jacquemin et al., 2012).
Studies of functional properties of A-T missense mutations
found varying ATM protein levels and abnormal enrich-
ment of cytoplasmic ATM protein (Jacquemin et al.,
2012). Mouse models of A-T have been limited to standard
knockout strategies that are normally homozygotic
(Barlow et al., 1996; Xu et al., 1996). Because mutations
may lead to expression of a portion of the ATM protein or
even a full-length ATM protein lacking key regulatory sites,
there is a possibility of partial function or dominant-nega-
tive function in A-T. For this reason, we sought to develop a
collection of human A-T induced pluripotent stem cells
(iPSC) for functional studies.
We previously discovered that ATM, in addition to
serving many roles in cell-cycle regulation and DNA dam-
age response, also functions as a key epigenetic regulator
in neurons, likely underlying the ataxic symptoms as well
as neurodegeneration. ATM indirectly regulates nuclear-
cytoplasmic shuttling of HDAC4 (Li et al., 2012), and it
directly phosphorylates EZH2, the enzymatic component
of the PRC2 complex (Li et al., 2013). Each of these mech-
anisms contributes to ataxia symptoms in knockout mouse
models, because reversal restores behavioral function. ATMStem Cell Repalso phosphorylates TET1, leading to conversion of 5mC to
5hmC marks, thought to be a key step in DNA demethyla-
tion (Jiang et al., 2015). Others have reported an effect on
the DNMT1 methyltransferase via ATM phosphorylation
of the Rb protein (Shamma et al., 2013). Any or all of these
mechanisms could be affected or modulated by domains
within a truncated ATM protein.
Although others have reported A-T iPSC (Nayler et al.,
2012; Lee et al., 2013; Fukawatase et al., 2014), there has
been no systematic preparation of a range ofATMmutation
sites and no broad assessment of genome stability in iPSC
cultures. It is expected thatmutations occur spontaneously
in tissue culture and presumably even in vivo. We exam-
ined several A-T iPSC lines and sublines derived from indi-
vidually picked colonies for evidence of such reversion. We
found that iPSCmade from one subject yielded phenotypic
and genotypic differences among sublines. Analysis of the
resulting isogenic pair of cell lines greatly focuses the iden-
tification of cellular mechanisms, such as gene expression
differences with or without ATM.RESULTS
Blood samples were obtained from six subjects harboring
previously identified ATM mutations (Figure 1A): two
from subjects diagnosed with A-T (labeled as ‘‘Q’’) and
four from carrier parents (labeled as ‘‘CAR’’). iPSC were pre-
pared from four of these subjects (asterisks in Figure 1A) us-
ing enriched, activated T cells and non-integrating Sendaiorts j Vol. 5 j 1097–1108 j December 8, 2015 j ª2015 The Authors 1097
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Figure 1. A-T iPSC Characterization
(A) Subject and iPSC line information. Six subjects were collected from the Johns Hopkins University Medical Center A-T Clinic with the
characteristics shown. The names of iPSC lines derived from each subject are listed separately from source subject codes. *Subject samples
used for iPSC reprogramming. The predicted patterns of ATM translation from each allele are shown for JHU_Q1 and JHU_Q3.
(B) Pluripotency markers in iPSC cultures. Example immunocytochemical images for each iPSC line showing nuclear OCT4 (green) and cell
surface TRA-1-60 (red) staining. The scale bar represents 10 mm.
(C) Gene expression analysis (RNA-seq) results were clustered to show expression patterns consistent with pluripotency. Samples of
unrelated iPSC, hESC-derived NSC at 0 or 5 days of neuronal differentiation (NSC0 and NSC5), and iPSC-derived midbrain-like DAN were
included for comparison. NSC0, NSC5, DAN, and iPSC, n = 3; Q1SA, Q3SA, and Q3SC, n = 2.
(legend continued on next page)
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viral vectors to deliver reprogramming factors (Moore et al.,
2012). Sample iPSC colonies from each subject had stan-
dard morphology and stained positive for Oct4 and TRA-
1-60, as shown in Figure 1B. For each subject, several sub-
lines were picked from single colonies, expanded, and
stored as frozen stocks. A subset of these was tested for
gene expression patterns consistent with pluripotency. As
shown in Figure 1C, three iPSC sublines (Q1SA, Q3SA,
and Q3SC) all clustered with unrelated iPSC prepared
from a non-A-T subject (‘‘iPSC’’), but they clustered sepa-
rately fromH1 human embryonic stem cell (hESC)-derived
neural stem cells (NSC) at day 0 (NSC0) or NSC following
5 days of differentiation (NSC5) (Sauvageau et al., 2013),
as well as dopaminergic neurons (DAN) differentiated
from iPSC using the dual-SMAD protocol (Kriks et al.,
2011). Furthermore, analysis of gene expression patterns
using the PluriTest algorithm (Mu¨ller et al., 2011) identifies
each iPSC line as being consistent with pluripotency (pluri-
raw valuesR 27, novelty% 1.8). These results demonstrate
successful iPSC reprogramming.
To confirm the presence of ATM gene mutations, we as-
sessed ATM protein expression by western blot (Figures
1D, S1A, and S1B). A band corresponding to full-length
ATM protein was clearly visible in the CAR3 and Q1SA
iPSC lines, as expected (Figure S1A). Q1SA encodes a
missense mutation (c.7181 C > T; encoding S2394L, Fig-
ure 1A) that is predicted to affect ATM activity but not
translation of full-length protein. However, independent
sublines prepared from subject JHU_Q3 expressed unex-
pected variation in ATM expression (Figures 1D and S1B).
Some sublines had no ATM protein, as expected (sublines
Q3SA, Q3SE, and Q3SI), but others expressed full-length
protein (Q3SC and Q3SG). Furthermore, different passage
numbers from the same subline exhibited varying quanti-
ties of ATM protein, peaking at P7 and then diminishing
but not disappearing in later passages (Q3SC; Figures 1D
andS1B).We selected two sublines,Q3SAandQ3SC, as con-
trasting examples without or with ATM expression, respec-
tively. ATM activity in sample iPSC lines was confirmed by
the X-irradiation (XR)-induced phosphorylation of CHK2(D) Western blot to detect ATM protein expression in Q3-specific iPSC
three western blots.
(E) Western blot to detect XR-induced pCHK2. Cultures were pre-treated
and XR blots, the white space separates two regions from the same b
(F) Immunocytochemical detection of gH2A.X nuclear puncta induced
in Figure S1C. The scale bar represents 10 mm.
(G) Assays to detect exon skipping in ATM mRNA. PCR primers were de
The predicted product for skipping Exon 4 would be 187 bp and intact
Skipping Exon 53 would produce a 95 bp product, which was not obs
(H) Allele frequencies in ATM mRNA. PCR products including the muta
individual molecules, and sequenced. The p value indicates the prob
50:50 ratio, according to chi-square analysis. The observed numbers
c.216-217 delAG = 0, and c.7792 C > T = 8.
Stem Cell Repas detected by western blots (Figure 1E). The pCHK2 band
was enhanced by XR (8 Gy) and diminished by pre-treat-
mentwith theATM-specific inhibitorKU-55933 (KU) inun-
related control iPSC (SC1) and in Q3SC. Little pCHK2 was
detected in Q1SA. Results were confirmed by observing
the presence of XR-induced gH2A.X nuclear puncta with
the same cell lines exhibiting positive (CAR3 and Q3SC)
or negative (Q1SA and Q3SA) results (Figures 1F and S1C).
Therefore, Q1SA expressed full-length ATM protein but
had little or no kinase activity, presumably because of the
presenceof apreviouslyunreportedC>Tvariant at position
c.7181, producing a S2394L that apparently affects activa-
tion. However, results indicate both the presence of ATM
protein and its function in the Q3SC subline where none
was expected on the basis of the diagnostic genotype pro-
vided with the subject cells. Results from Q3SA matched
those expectations, as no ATM protein or activity was
observed, with one allele terminating shortly after a frame-
shift mutation (c.217_218 delGA) and the other allele ter-
minating at a point mutation (c.7792 C > T; R2598X),
each truncating translation prior to the kinase domain.
Several possibilities could explain the aberrant expression
ofATMinQ3SC.Exonskippinghasbeenobserved in several
genes (Dutertre et al., 2010;Nevoet al., 2012) and is believed
to be influenced by ATM function (Tresini et al., 2015). By
amplifying cDNA with PCR primers targeting sites outside
of exons which contain mutations in Q3 (sequences found
in Table S1), only full-length product was identified,
providing no evidence formRNA skipping those exons (Fig-
ure 1G). We also counted the frequencies of sequenced,
clonedPCRproducts corresponding toeachallele and found
only the c.7792 C > T allele mixed with wild-type sequence
in Q3SC: there was no evidence of the c.217_218 delGA
allele in the mRNA, as was found in CAR3 (Figure 1H).
Thiswouldbe consistentwithgene reversion,becausea sim-
ple deletion could not generate a wild-type allele.
The mutation sites were directly examined by
sequencing of crude PCR-amplified segments of genome.
As shown in Figure 2A, Q3SA exhibits the mutations iden-
tified in the diagnostic genotyping originally provided forsublines. See also Figures S1A and S1B. Results were replicated in
with 10 mM KU or DMSO vehicle 1 hr prior to irradiation. For both NR
lot. Results were replicated in two western blots.
by XR. Controls (NR and XR with/without KU inhibition) are shown
signed for exons upstream or downstream of mutations in JHU_Q3.
Exon 4 would be 333 bp. Only the latter size product was detected.
erved.
tion sites were prepared from cDNA, cloned into plasmids to isolate
ability of observing these frequencies compared with an expected
of sequences were CAR3 c.216-217 delAG = 3, wild-type = 4; Q3SC
orts j Vol. 5 j 1097–1108 j December 8, 2015 j ª2015 The Authors 1099
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Figure 2. Genetic Analysis of A-T iPSC
(A) Sequencing traces of unpurified genomic PCR products. Homozygous sequences appear as a single pattern, and heterozygous sequences
show a mixture of the two alleles distal from the point of difference (highlighted in yellow). The presence of the c.217_218 delGA deletion
is visible as multiple overlapping traces in Q3SA and CAR3. The c.7792 C > T substitution is visible in Q3SA and Q3SC. Other samples were
wild-type (similar to unrelated SC1) at these locations.
(B) Loss of the c.217_218 delGA variation over passaging of Q3SC. DNA samples from passage 4 (P4) or 10 (P10) identified the presence of
this variation at P4 but not at P10.
(C) Hierarchical SNP clustering demonstrates genetic relationships among iPSC from genome-wide SNP arrays. Clustering used Euclidean
distance by substituting 1 for AA, 0 for AB, and 1 for BB. Also indicated are the imputed genders based on SNPs.
(D) Karyotype of Q3SC. A representative chromosomal spread is shown for Q3SC, which was found to be 46 XY in 20 of 20 cells.
(E) Map of SNPs detected by re-sequencing genomic DNA near c.217_218 delGA. The positions of the deletion and the one SNP exhibiting
LOH are identified by arrows.
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subject JHU_Q3 (Figure 1A). Each mutated location was
clearly heterozygous in Q3SA, as evidenced by the mixed
trace from the unpurified PCR product (highlighted in yel-
low). CAR3 exhibited the c.217_218 delGA mutation,
which is consistent with a parental relationship to
JHU_Q3. Q3SC, on the other hand, is missing the
c.217_218 delGA mutation, because only wild-type
sequence is visible in the PCR products. The c.7792 C > T
mutation is present in both Q3SA and Q3SC. The same
pattern of mutations appears in sequenced, PCR-amplified
segments of cDNA (not shown), suggesting that both al-
leles are transcribed. These results predict that Q3SC carries
one allele capable of encoding a full-length ATM protein,
while Q3SA does not.
Because the ATM western blot (Figure 1D) appears to
show different quantities of ATM protein at different pas-
sage numbers of Q3SC, we wondered if early passage cells
might have a different genotype from later passage cells.
Early passage (P4) DNA prepared from Q3SC exhibited
c.217_218 delGA in one allele, matching Q3SA and the
diagnostic genotype for the JHU_Q3 subject, but later
passage cells (P10) lacked this mutation (Figure 2B). This
suggests that the Q3SC iPSC culture may have acquired a
spontaneous gene reversion during early passaging. Alter-
natively, this culture could have suffered from cross-
contamination. The latter seems unlikely, because the
ATM mutation genotype for Q3SC does not match the
maternal heterozygous carrier that we had thawed and re-
programmed (CAR3) but instead matches the imputed ge-
notype and gender of cells from the father (CAR4), from
whom we stored blood samples that have never been
thawed or cultured in our laboratory.
To rule out the possibility of cross-contamination, we
evaluated large numbers of genomic variations using
SNP arrays. Clustering with the Euclidean distance be-
tween called SNPs, DNA from both Q3SA and Q3SC are
quite similar to DNA prepared from the amplified
JHU_Q3 T cells originally used for reprogramming
(Q3SA: 699,368 SNPs match JHU_Q3 out of 701,230
called SNPs [99.73%]; Q3SC: 99.85%; Figure 2C). Less
closely related is the DNA from the parent CAR3
(71.95%), the unrelated Q1SA iPSC line (55.65%), or its
source JHU_Q1 T cells (55.64%). This confirms that
Q3SA and Q3SC are iPSC lines made from the same source
individual (JHU_Q3), who is related to JHU_CAR3, but not
to the source T cells or iPSC prepared from JHU_Q1.
Furthermore, on the basis of SNPs, Q3SA and Q3SC are
confirmed as male and both Q1SA and CAR3 are
confirmed as female, consistent with designated cell sour-
ces. SNPs overlapping those recommended for use in cell
line identification (Yu et al., 2015) are shown in Table
S2. The ATM-expressing Q3SC, then, is not due to cross-
contamination of cultures.Stem Cell RepWe then searched for evidence of sequence variation in
Q3SC. The karyotype of Q3SC was normal (Figure 2D;
46,XY in all 20 cells counted). SNP data were evaluated
for evidence of loss of heterozygosity (LOH). Plots of the
B allele frequency over the entire genome (not shown) or
over the region of chr11 surrounding the ATM gene (Fig-
ure S2A) show no clear evidence for LOH overall but a
lack of any heterozygous SNPs within the ATM gene, pre-
cluding the ability to assess LOH within the gene itself.
However, the presence of SNP heterozygosity flanking
ATM in all cell lines argues against a single crossing-over
event between alleles, as this would have produced LOH
distal from the event. By highlighting the 1,034 SNPs
that distinguish Q3SA or Q3SC from source T cells (Fig-
ure S2B, colored dots) it is apparent that there is no concen-
trated genomic region of LOH between these two sublines,
but that sequence variation has accumulated throughout
the genome. Similar plots of the signal intensity of SNPs
(log R ratio, not shown) show little evidence for copy-num-
ber variation (CNV) near the ATM gene. Not all known
SNPs are included on the SNP array, so a 3.5 kb region sur-
rounding the c.217_218 delGA site was re-sequenced. Only
one SNP, rs2066734, was found to be heterozygous inQ3SA
(red dot, Figure 2E). This SNP was homozygous for the ma-
jor allele in Q3SC (green) and homozygous for the minor
allele in CAR3 (blue). By estimating the rate of random
SNP LOH using the SNP array data, a Fisher’s exact test in-
dicates that the probability of finding a specific LOH for
rs2066734 within ATM but unrelated to the loss of
c.217_218 delGA is p = 0.00014. This indicates that the
most likely source of reversion was a short gene correction
event, including at least 1.5 kb upstream of c.217_218
delGA to include rs2066734. This result also confirms
that the maternal allele, containing the c.217_218 delGA
deletion as well as the minor rs2066734 allele, is lost in
Q3SC and is replaced by a copy of the paternal allele
sequence, explaining the absence of mutation at this posi-
tion. Becausemutation at c.7792 is heterozygous, reversion
of c.217_218 delGA to wild-type sequence would be suffi-
cient to produce a genotype of ATM+/.
To evaluate possible genomic rearrangement and CNVof
ATM in individual cells, we used a fluorescence in situ hy-
bridization (FISH) probe specific for the ATM gene
(chr11:108,089,374–108,241,929 in the hg19 genome).
Results indicated that amajority of cells had an equal num-
ber of ATM-specific puncta as those specific for a chr11
centromere control FISH probe (Figure 3A, ‘‘Normal’’). A
much smaller percentage of cells had one ATM singlet
punctum and a doublet puncta comparedwith two singlets
for chr11 control (‘‘SD’’), indicating asynchronous DNA
replication. ATM-deficient cells have difficulties respond-
ing to oxidative stress in cell culture, and they may have
diminished control of asynchronous DNA replication dueorts j Vol. 5 j 1097–1108 j December 8, 2015 j ª2015 The Authors 1101
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Figure 3. Genetic Variation in A-T iPSC
(A) FISH analysis identifies similar proportions of cells with normal, ‘‘SD’’ (unequal number of puncta for ATM compared with chr11
centromere), and ‘‘AP’’ (aneuploid) in CAR3, Q1SA, Q3SA, Q3SC, or unrelated control (SC1). Example images are shown for comparison
(green, ATM; red, chr11 centromere). The scale bar represents 10 mm. Cells classified as ‘‘AP’’ are likely apoptotic. Total cells counted: SC1,
n = 111; CAR3, n = 131; Q3SA, n = 123; Q3SC, n = 132; and Q1SA, n = 100.
(B) XR-induced pATM in iPSC following mutagenesis. Cultures were treated with 1 Gy XR once to induce mutagenesis and then again 1 week
later to activate ATM autophosphorylation. The fraction of XR-induced pATM-positive nuclei is plotted for each iPSC line, with XR or
without (NR) stimulation (n = 4 wells). This assay was repeated with cells from a different passage number with essentially identical results
(not shown).
(C) Examples of immunocytochemically detected pATM and gH2A.X puncta are identified with arrows. The scale bar represents 10 mm.
(legend continued on next page)
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to deficiencies in p53 signaling (Nagler et al., 2010). Rarely,
cells were characterized as aneuploid (‘‘AP’’) that likely re-
flected early stages of cell death. There were no significant
differences in these percentages across genotype (ATM/
versus ATM+/) or iPSC line. This indicates that no deletion
or duplication of the ATM gene was detected, even in a sub-
set of cells and therefore there was no evidence for cell-to-
cell variability in ATM gene copy number.
Because the results suggested that gene correction may
have occurred during the early passaging of Q3SC, we
asked whether any of the ATM/ iPSCs could be reverted
in culture. To increase the chances of observing rare events,
96-well plates containing wells with CAR3, Q1SA, Q3SA, or
Q3SC iPSCwere X-irradiated at 1 Gy to promote DNA dam-
age and induce genetic recombination or repair events.
One week later, the cultures were irradiated again to acti-
vate ATM, and after 30 min of response time, all cultures
were fixed, stained for phospho-ATM (pATM) and
gH2A.X, and then imaged (Figure 3B). A parallel plate
with no radiation treatment served as negative control.
Automated counting of the fraction of pATM-containing
nuclei indicated XR-induced ATM autophosphorylation.
The ATM+/ lines, CAR3 and Q3SC, each had robust in-
creases in pATM following XR. Q1SA, which encodes a
full-length ATM protein with a S2394L variation, appeared
to induce phosphorylation at S1981, the epitope for the
phospho-specific ATM antibody, but this increase was
similar to non-irradiated (NR) background. Similarly, the
ATM/ Q3SA appeared to show a weaker trend of XR-
induced pATM activity that was not different from NR.
To determine if any evidence for functional ATM could
be detected, we searched images for coincident pATM and
gH2A.X staining (Figure 3C). Q3SC and CAR3 had robust,
overlapping puncta, as expected. However, rare nuclei
could be identified in both Q1SA and Q3SA that had not
only pATM puncta but also overlapping gH2A.X puncta,
indicating that ATM was expressed, autophosphorylated,
and likely functional in triggeringH2A.X phosphorylation.
In the case of Q1SA, it is possible that the variation at S2394
was not sufficient to completely inhibit ATM activation in
all cells, even though assay of gH2A.X in the absence of XR
was negative (Figure 1F). However, the presence of a weak
signal of pCHK2 (Figure 1E) along with the trend of occa-
sional pATM and gH2A.X activation in Figure 3C suggests
that the variant of ATM expressed in Q1SA is capable of
phosphorylating downstream targets in a small number
of cells. However, detection of pATM and gH2A.X staining
in a very small number of Q3SA cells could not be ex-(D) Clustering of PCR-amplified TCRb junction sequences from various
into three clusters, labeled A, B, and C. Sequence alignments matc
clustering samples from several iPSC lines show distinct patterns gen
(E) Interpretation of cluster sequence frequencies calculated from re
Stem Cell Repplained by the genotype of these cells, and therefore it is
possible that the same type of gene reversion had occurred
as that detected inQ3SC. These results indicate that the A-T
iPSC are generally stable, at least over the period of this
assay, but that XR-induced reversion can be detected at
low frequencies in both Q1SA and Q3SA cells.
Because reversion is a very rare event we wondered how
Q3SC transitioned so quickly from ATM/ to ATM+/
(most likely between P4 and P10; see Figure 2B). Because
these iPSC lineswere prepared fromTcells, we had a unique
opportunity to trace individual subject cells during the re-
programming and growth stages in preparing iPSC. Mature
T cells have rearranged genomic T cell receptor (TCR) and
this rearrangement is unique to individual T cells. There-
fore, we PCR-amplified genomic DNA from iPSC from
various cell lines or passage numbers to detect rearranged
TCRb variable region using primers validated previously
(Assaf et al., 2000). The PCR products were inserted into
plasmids, and individual clones were sequenced. Align-
ment of these sequences from several passages of Q3SC in-
dicates evidence for a varying number of ‘‘founder’’ T cell
signatures in early passage that transitioned to a single
type of signature in later passages (Figures 3D and S3A).
This indicates that each iPSC line (derived from a single col-
ony) was not produced from a single cell but instead
included multiple ‘‘founder’’ cells, each presumably
derived from independent reprogramming events. The se-
quences specific for Q3SC are distinct from those from
Q3SA or Q1SA (Figure S3B), indicating that separate lines
came from independent mixtures of founders. Q3SC re-
sults are summarized by the percentage of each of threema-
jor clusters by frequency of aligned TCRb sequence (Fig-
ure 3E). Clusters A and B, present as the majority of
detected sequences at P4, disappeared over further
passaging. Cluster C expanded from 33% at P4 to 83% at
P10 and to 100% at P20. This means that the ATM rever-
sion event could have occurred either in the original
Tcells or early after reprogramming of iPSC in an individual
‘‘clone’’ of founder cells, which then expanded to over-
come the others. Sequencing traces of crude, PCR-ampli-
fied DNA from P4 (Figure 2B) had no evidence for reverted
c.217_218 delGA. If 33% of the DNA were indeed previ-
ously reverted, the mutated allele at c.217_218 delGA
should constitute only 33% of the P4 mixed traces in Fig-
ure 2B instead of the 50% expected if the culture were
entirely ATM/, and this is nearly impossible to judge
from anon-quantitative sequence trace. Themost parsimo-
nious interpretation is that reversion occurred early afterpassages of Q3SC. The vertical dashed line cleaves the dendrogram
hing this dendrogram are shown in Figure S3A. As a comparison,
erally specific for each line (Figure S3B).
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reprogramming in the cluster C iPSC of Q3SC, possibly
when this cluster was present as a single cell.
Because Q3SA and Q3SC represent an isogenic pair of
iPSC lines from the same individual but with contrasting
ATM genotypes (ATM/ versus ATM+/, respectively), we
examined gene expression differences using RNA
sequencing (RNA-seq), evaluatingmatches at the transcript
level. Relatively few mRNAs were significantly different in
the isogenic Q3 pair (206, false discovery rate [FDR] %
5%), as contrasted with a much larger number of differ-
ences between Q1SA and Q3SC (1,349), even though
both contrasts compared ATM/ with ATM+/ (Figures
4A–4C). This indicates that observed gene expression dif-
ferences due to variations in genetic backgrounds generally
overwhelm any analysis of single-gene, variant-specific dif-
ferences. Out of the 206 transcripts different in the isogenic
pair of cell lines (Table S3), 113 (54.8%) also differed be-
tween Q1SA and Q3SC (Figure 4A). On the other hand, a
large proportion (601 of 1,349 [44.6%]) of transcripts
differing between Q1SA and Q3SC were in common with
the Q1SA versus Q3SA comparison (Figure 4B), even
though the latter compared two differentATM/ cell lines.
Nayler et al. (2012) identified 7,920 genes as significantly
different in A-T iPSC compared with wild-type cells using
the same selection criteria. This list translated to 7,402
unique RefSeq transcript identifiers, and only 50 of these
overlapped with the 206 Q3SA versus Q3SC transcripts
found here. Three hundred sixty-four of Nayler’s selected
transcripts overlapped with the broader Q1SA versus
Q3SC list, again indicating that comparisons between
isogenic pairs are distinct from those between cell lines
with different genetic backgrounds.
Looking to functional characterization of the transcripts
selected as diminished in Q3SA compared with Q3SC, the
top enriched pathway was p53 signaling (p = 1.63 3
104; Figure 4D). This is reinforced by upstream analysis,
in which TP53mRNAwas reduced24-fold in the absence
of ATM, and 18 of 19 genes predicted to be transcription-
ally regulated by p53 were affected (p = 3.463 105). Other
pathways enriched by the reduced transcripts included
IGF-1 signaling, acute phase response signaling, and the
Wnt/Ca+2 pathway (Figure 4D). Few pathways were en-
riched in the list of transcripts increased inQ3SA compared
withQ3SC, and these had no clear biological interpretation
(Figure 4D). Under normal conditions in the absence of
ATM stimuli such as double-stranded breaks, the primary
cellular effect is a reduction in p53 signaling.DISCUSSION
Spontaneous genetic variation has been described in
cultured cells almost from the beginning of genetic analysis1104 Stem Cell Reports j Vol. 5 j 1097–1108 j December 8, 2015 j ª2015 Thin cell culture. In one example, published in 1968, Atkins
and Gartler proved that the mutation rate in culture is
the same whether selection is applied or not (Atkins and
Gartler, 1968). However, there has been relatively little
report of spontaneous reversion in iPSC created from ge-
netic variant cells, except for cases in which naturally
occurring reversion of cultured primary cells have been re-
programmed into iPSC (Tolar et al., 2014; Maclean et al.,
2012). Careful studies demonstrate that much of the varia-
tion between iPSC lines may be attributed to genetic varia-
tion in source skin fibroblasts (Abyzov et al., 2012) and that
skin cells accumulate mutations in situ (Martincorena
et al., 2015). Our results show that cultured iPSC have the
capacity to undergo genetic rearrangement, in this case a
reversion from ATM/ to ATM+/. All available evidence,
including at least the 1.4 kb spanning the c.217_218 delGA
position to the location of rs2066734, supports the conclu-
sion that gene conversion of ATM occurred, replacing the
maternal allele with a copy of the paternal allele to create
an allele encoding full-length ATM protein capable of
phosphorylating pCHK2 and gH2A.X upon XR. This likely
occurred between initial reprogramming of the iPSC line
(P0) and P10, as DNA prepared from P4 had not reverted,
or at least not detectably. One puzzling aspect was that
the ATM protein levels detected by western blotting ap-
peared to change over passaging (Figure 1D). It is not clear
if this is meaningful in the context of our study, as ATM
protein remained detectable after the reversion event,
even if levels were reduced. Alternatively, ATM gene rever-
sion could have occurred in circulating T cells prior to
reprogramming. Even if this were the case, Figure S2B dem-
onstrates that independent SNP variants accumulate after
reprogramming, proving that iPSC cultures accumulate ge-
netic variants during culture.
Analysis of TCRb signatures predicts that several initial
‘‘founder’’ clones of iPSC were present at P4 but that these
resolved to a single clone by P20. This was somewhat sur-
prising, as it is often assumed that individually picked col-
onies of iPSC are derived from a single cell and are therefore
clonal. Our results demonstrate that this is not the case. In
other studies, we found that multiple founder cells are
found inmost iPSC colonies using both Tcell receptor rear-
rangement and by mixing source cells of different gender.
There was no overt selection for ATM reversion among
the multiple founder cell-derived iPSC, although we pre-
sume that the gain of ATM function, with its diverse roles
regulating cell cycle, DNA repair, and epigenetic mecha-
nisms, may have a selective advantage in the stressful envi-
ronment of culture.
Many alternative explanations for this change in geno-
type were considered and discarded. No evidence for
exon skipping or allele-specific mRNA expression could
be detected. SNP analysis proves that the reverted cellse Authors
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Figure 4. Gene Expression Analysis in A-T iPSC
(A) Volcano plot comparing changes in transcript (as log2 fold change of fragments per kilobase of transcript per million mapped reads)
and significance (log10 of the FDR) for Q3SA versus Q3SC. Sample names are color-coded by genotype: red for ATM/ and blue for
ATM+/. The significance threshold of 5% FDR is shown as a horizontal dashed line (n = 2 per group). Smaller gray dots indicate transcripts
with no significant difference. Colors of dots indicate whether transcripts overlap Q1SA versus Q3SC or not: see key and the colors of
overlapping regions in the Venn diagram (C) for color interpretation.
(B) Volcano plot comparing Q1SA with Q3SC, with dot coloring to show overlap with Q1SA versus Q3SC.
(C) Venn diagram indicating the numbers of significantly different transcripts in each contrast and the numbers of overlaps among the
contrasts.
(D) Pathway analysis of transcripts that are decreased in abundance in Q3SA compared with Q3SC (top) or increased (bottom). The bar
indicates the p value calculated by Fisher’s exact test, and the color intensity depicts the ratio of pathway genes included in this
differentially expressed set.matched the source subject T cells as well as another iPSC
subline that had not reverted. Other types of crossover
events should have produced large regions of LOH or
changes in copy number, and neither of these was found.
An attempt to induce reversion with XR-induced muta-
genesis revealed isolated cases of cells staining positive forStem Cell Repboth pATM and gH2A.X inQ3SA cultures that should carry
two mutated alleles to produce only truncated proteins.
These small numbers of apparently reverted cells did not
rise to the level of significance when assessed by automated
counting of all available wells, so one might argue that
these spontaneous events occur at an exceedingly loworts j Vol. 5 j 1097–1108 j December 8, 2015 j ª2015 The Authors 1105
level, if at all, in the absence of mutagenesis. On the other
hand, we found pATM and gH2A.X staining cells in Q1SA,
which expresses a missense mutation from one allele.
These cells, harboring a variant encoding S2394L, could
potentially have destroyed a site of autophosphorylation,
but a previous search did not identify this serine residue
as phosphorylated (Kozlov et al., 2011). On the basis of
the possibility that this variant was ‘‘leaky’’ for ATM func-
tion, we could not distinguish if actual gene reversion
had occurred or if ATM had been activated in only a small
proportion of cells. The absence of gH2A.X staining
without the mutagenic XR (Figure 1F) argues against this,
but there have been cases reported of incomplete inactiva-
tion of ATM with other mutations (Stewart et al., 2001).
The fact that both Q3SA and Q1SA cultures have been
passaged in our lab for several months argues that if rever-
sion does occur spontaneously, there is unlikely to be a
strong functional selection for the reversion, because we
have not yet observed a change in apparent genotype.
Having the unexpected but fortuitous case of two iPSC
lines made from the same individual but with contrasting
ATM genotypes, we assessed baseline gene expression pat-
terns. The results clearly indicate that the mRNA patterns
affected by the lack of ATM function primarily relate to
p53 pathways. In support of this interpretation, upstream
regulator analysis also identified a pattern of regulation
not only of the gene encoding p53 (TP53) but also the ma-
jority of transcriptional targets downstream of this key pro-
tein. It will be invaluable to continue these analyses in
future studies to identify patterns of mRNA changes
following the induction of DNA damage. Most important,
however, the regulated mRNA patterns comparing Q3SA
with Q3SC are much more focused than a comparison be-
tween unrelated cultures having the same genotypes
(Q1SA versus Q3SC). Previous studies (Nayler et al., 2012)
analyzed similarly diverse A-T versus control cultures and
concluded that other pathways, including mitochondrial
function, might be directly affected by the loss of ATM
function. Our results, although identifying a core set of
genes in common with those of Nayler’s study (Nayler
et al., 2012), show that only by contrasting an isogenic
pair of cells can the clearest functional patterns be revealed.
Reversion of an A-T iPSC line proved to be a valuable ac-
cident. However, the fact that an iPSC line derived from an
A-T subject reverted at all provides a cautionary tale for
those culturing gene variants in stem cells. Clearly, varia-
tions occur randomly in culture. As an example (Fig-
ure S2B), two different sublines prepared from the same in-
dividual exhibited 1,034 SNP variations from source cells
independent of the ATM gene reversion. This rate of varia-
tion predicts that as many as 43 106 bp may vary between
these lines across the entire genome. Clearly it is important
that a gene variation of interest be monitored over growth1106 Stem Cell Reports j Vol. 5 j 1097–1108 j December 8, 2015 j ª2015 Thof iPSC cultures, just as it is important to monitor cultures
for evidence of cross-contamination (Yu et al., 2015). These
results demonstrate that iPSC cultures must be evaluated
continuously to ensure that the cells appropriately repre-
sent the genetic model being investigated.EXPERIMENTAL PROCEDURES
Cell Source and Reprogramming
Standard blood samples were obtained from the Johns Hopkins
A-T Clinic, with approval from the Johns Hopkins IRB
(#NA_00077304), and shipped to RUCDR Infinite Biologics. Re-
programming from activated T cells using Sendai viral vectors ex-
pressing Oct4, Sox2, Klf4, and Myc (Cytotune; Life Technologies)
followed protocols described previously (Moore et al., 2012). All
iPSC cultures are grown under low (4%) O2 conditions (Guo
et al., 2013). Procedures at Rutgers were confirmed as exempt by
the Rutgers institutional review board (#E13-825). Individual ‘‘sub-
lines’’ were picked from a single, primary colony of iPSC.
RNA-seq
RNAwas prepared from frozen iPSC pellets using Trizol (Life Tech-
nologies). RNA-seq was performed at RUCDR Infinite Biologics us-
ing Illumina technology and analyzed as described previously
(Kraushar et al., 2014). The accession number for the A-T cell line
RNA-seq experiments reported in this paper is GEO: GSE71878.
The RNA samples used for comparison in Figure 1B were obtained
froma previous study (NSC; Sauvageau et al., 2013) or fromunpub-
lished results from our lab.
Immunocytochemistry
Cultured cells were fixed in 4% paraformaldehyde. Primary anti-
bodies were obtained from EMD Millipore (Oct-4 [clone
10H11.2], TRA-1-60 [MAB4360], gH2A.X [phospho-Ser139]) or
from Abcam (P-ATMs1981 [ab36810]). Imaging was performed
on an IN CELL 6000 automated confocal microscope system (GE
Biosciences).
Western Blots
Proteins were extracted, run on precast NuPage 3%–8% acrylamide
gels, transferred to Immun-Blot PVDF membrane (Bio-Rad), and
detected with primary antibody andHRP-coupled secondary using
Luminol reagent (Santa Cruz Biotechnology). Primary antibodies
were obtained from Abcam (ATM [Y170, 2C1A1]), Cell Signaling
Technology (Danvers MAT) (pCHK2 [phospho T68]), and Santa
Cruz (actin [SC-1615]).
PCR and Sequencing
Genomic DNA was prepared using Zymo gDNA columns (Zymo
Research), and specific regions were amplified by PCR using
primers listed in Table S1 using Q5 mastermix (New England Bio-
labs). PCR fragments were cloned using the StrataClone Blunt
PCR cloning kit (Agilent). Sequencing was performed by Gen-
Script. ATM mutations were compared with annotations in the
LOVD database (http://atm.lovd.nl). TCRb junction sequences
were identified by amplification with the Jb1 family of primerse Authors
and the Vb pan primer from Assaf et al. (2000). Amplified frag-
ments were cloned into the Stratagene Blunt PCR cloning kit
(Agilent) and sequenced with an M13R vector-specific primer.
SNP Arrays
Genomic DNA samples were run on Illumina Human OmniEx-
press SNP arrays at RUCDR Infinite Biologics. Data were analyzed
using Illumina GenomeStudio software and R/Bioconductor.
Karyotyping
Karyotyping was performed by RUCDR Infinite Biologics.
FISH
Fluorescent SureFISH probes were purchased from Agilent Tech-
nologies (SureFISH 11q22.3 ATM 153kb and SureFISH Chr11 CEP
798kb). iPSC were spread on positively charged glass slides using
protocol reported previously (Moralli et al., 2011). FISH was per-
formed following Agilent protocol. Probes were visualized by a Le-
ica DM5000B fluorescence microscope. Probe signals were
enumerated in 200 cells for each iPSC subline.
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